Clinical Trial Update: Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) [Phase 4]

View source ↗

Summary

A Phase 4 trial of oral posaconazole in high-risk patients with gastrointestinal dysfunction (including neutropenia) has completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Fungal Infections

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infection, Acute Myelogenous Leukemia | Phase 4 | Status: COMPLETED | Results posted: 2010-05-14